SC
Savant Capital Portfolio holdings
AUM
$16.1B
1-Year Return
14.38%
This Quarter Return
+8.8%
1 Year Return
+14.38%
3 Year Return
+48.07%
5 Year Return
+73.78%
10 Year Return
+154.4%
AUM
$16.1B
AUM Growth
+$2.32B
(+17%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
7.67%
Top 10 Holdings %
Top 10 Hldgs %
39.16%
Holding
1,981
New
393
Increased
869
Reduced
537
Closed
138
Top Buys
| 1 |
Dimensional US Large Cap Value ETF
DFLV
|
+$115M |
| 2 |
Vanguard Growth ETF
VUG
|
+$88.4M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$87.8M |
| 4 |
Dimensional US Small Cap Value ETF
DFSV
|
+$70.4M |
| 5 |
Vanguard Total Bond Market
BND
|
+$64.8M |
Top Sells
| 1 |
Dimensional US Marketwide Value ETF
DFUV
|
+$24.4M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$15M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$12.6M |
| 4 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$11.1M |
| 5 |
SW
Smurfit Westrock plc
SW
|
+$9.82M |
Sector Composition
| 1 | Technology | 6.06% |
| 2 | Financials | 3.47% |
| 3 | Industrials | 3% |
| 4 | Consumer Discretionary | 2.46% |
| 5 | Healthcare | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
VTEX
VTEX
$741M
| $69.6K | ﹤0.01% |
+10,540
| New | +$69.6K |
|
1777
Editas Medicine
EDIT
$248M
| $69.4K | ﹤0.01% |
31,560
+18,593
| +143% | +$40.9K |
|
1778
Akebia Therapeutics
AKBA
$795M
| $69K | ﹤0.01% |
+18,967
| New | +$69K |
|
1779
Standard BioTools
LAB
$489M
| $68.3K | ﹤0.01% |
56,957
+37,926
| +199% | +$45.5K |
|
1780
BRF SA
BRFS
$5.78B
| $68.1K | ﹤0.01% |
18,656
+2,599
| +16% | +$9.49K |
|
1781
MiMedx Group
MDXG
$1.05B
| $65.8K | ﹤0.01% |
10,773
-1,212
| -10% | -$7.41K |
|
1782
Lexicon Pharmaceuticals
LXRX
$411M
| $65.8K | ﹤0.01% |
69,578
+17,348
| +33% | +$16.4K |
|
1783
Unisys
UIS
$279M
| $65.7K | ﹤0.01% |
14,496
-2,068
| -12% | -$9.37K |
|
1784
Compass
COMP
$4.88B
| $65.6K | ﹤0.01% |
10,447
-15,792
| -60% | -$99.2K |
|
1785
Nuvation Bio
NUVB
$1.15B
| $65.4K | ﹤0.01% |
+33,522
| New | +$65.4K |
|
1786
Hanesbrands
HBI
$2.25B
| $65K | ﹤0.01% |
+14,184
| New | +$65K |
|
1787
Energy Fuels
UUUU
$3.02B
| $64.9K | ﹤0.01% |
+11,284
| New | +$64.9K |
|
1788
Tango Therapeutics
TNGX
$759M
| $60.8K | ﹤0.01% |
+11,872
| New | +$60.8K |
|
1789
Bit Digital
BTBT
$890M
| $60K | ﹤0.01% |
+27,419
| New | +$60K |
|
1790
Zentalis Pharmaceuticals
ZNTL
$115M
| $58.8K | ﹤0.01% |
+50,727
| New | +$58.8K |
|
1791
Riskified
RSKD
$748M
| $57.5K | ﹤0.01% |
+11,515
| New | +$57.5K |
|
1792
Altice USA
ATUS
$1.12B
| $57.3K | ﹤0.01% |
+26,794
| New | +$57.3K |
|
1793
Tenaya Therapeutics
TNYA
$212M
| $52.1K | ﹤0.01% |
+85,283
| New | +$52.1K |
|
1794
Ribbon Communications
RBBN
$717M
| $52.1K | ﹤0.01% |
+12,995
| New | +$52.1K |
|
1795
Neumora Therapeutics
NMRA
$270M
| $51.6K | ﹤0.01% |
+70,432
| New | +$51.6K |
|
1796
SES AI
SES
$413M
| $51.6K | ﹤0.01% |
58,118
+14,118
| +32% | +$12.5K |
|
1797
Grab
GRAB
$21.6B
| $51K | ﹤0.01% |
+10,136
| New | +$51K |
|
1798
Banco Bradesco
BBDO
$29.2B
| $50.7K | ﹤0.01% |
+18,580
| New | +$50.7K |
|
1799
Shoals Technologies Group
SHLS
$1.11B
| $49.7K | ﹤0.01% |
+11,701
| New | +$49.7K |
|
1800
Neogen
NEOG
$1.24B
| $49.7K | ﹤0.01% |
+10,391
| New | +$49.7K |
|